Scilex Holding (SCLXW) Intangibles (2021 - 2026)

Scilex Holding (SCLXW) recorded quarterly Intangibles of $59.8 million in Q1 2026, down 34.84% quarter-over-quarter from $91.8 million in Q4 2025, and down 1.6% on a YoY basis from $60.8 million in Q1 2025.

Scilex Holding (SCLXW) Intangibles (2021 - 2026) Analysis & Trends

Scilex Holding's Intangibles history runs 6 years deep, the most recent figure standing at $59.8 million for Q1 2026.

  • In Q1 2026, Intangibles fell 1.6% year-over-year to $59.8 million; the TTM figure through Mar 2026 stood at $59.8 million (down 1.6% YoY), while the FY2025 annual figure was $91.8 million, up 51.0% from the prior year.
  • Intangibles was $59.8 million for Q1 2026 at Scilex Holding, down from $91.8 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $91.8 million in Q4 2025 to a low of $5.0 million in Q1 2022.
  • Historically, Intangibles has averaged $42.2 million across 5 years, with a median of $38.5 million in 2023.
  • The sharpest annual moves came in 2023 and 2025: Intangibles surged 1115.62% in 2023, then sank 48.27% in 2025.
  • A 5-year view of Intangibles shows it stood at $40.6 million in 2022, then soared by 49.74% to $60.8 million in 2023, then changed by 0.0% to $60.8 million in 2024, then surged by 51.0% to $91.8 million in 2025, then sank by 34.84% to $59.8 million in 2026.
  • The last three Intangibles figures came in at $59.8 million (Q1 2026), $91.8 million (Q4 2025), and $30.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 24.45 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 7.37 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 49.06 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 50.87 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 25.75 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 21.38 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 16.38 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 52.56 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 18.24 Bn
10 Scilex Holding - - 4.15 Mn 59.81 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 59.81 Mn
Dec 31, 2025 91.78 Mn
Sep 30, 2025 30.42 Mn
Jun 30, 2025 31.44 Mn
Mar 31, 2025 60.78 Mn
Dec 31, 2024 60.78 Mn
Sep 30, 2024 33.45 Mn
Jun 30, 2024 60.78 Mn
Mar 31, 2024 35.46 Mn
Dec 31, 2023 60.78 Mn
Sep 30, 2023 37.51 Mn
Jun 30, 2023 38.54 Mn
Mar 31, 2023 60.78 Mn
Dec 31, 2022 40.59 Mn
Sep 30, 2022 5.00 Mn
Jun 30, 2022 5.00 Mn
Mar 31, 2022 5.00 Mn
Dec 31, 2021 38.80 Mn